Kedalion Therapeutics is a clinical-stage, venture-funded ophthalmic drug company based in Menlo Park, CA. Kedalion's AcuStream technology delivers topical drugs to the eye in a precise and accurate manner that enables comparable efficacy with an 80% reduction in dose compared to standard drops, and a significantly improved side effect profile along with patient comfort and convenience following self-administration.

Biotechnology

Kedalion Therapeutics

Mark Blumenkranz

Mark Murray

Ehud Ivri

Casey Dougan

Joseph Gilbert

Reynaldo Quintana

The founding team at Kedalion Therapeutics has a wealth of experience and expertise in the field of engineering, specifically in mechanical engineering. They have applied their skillsets in a variety of industries, including healthcare and pharmaceuticals. This team has a proven track record of success, having founded and led multiple companies to success.

Founding Team

Board of Directors

Leadership Team

CEO and Executive Team

Founding Team

About

Team members

Other teams at Kedalion Therapeutics

Board of Directors

Leadership Team

CEO and Executive Team